September 27, 2013

Ipsen Relocating to Cambridge

After selling its hemophilia drug program to an Illinois company earlier this year, Ipsen has announced it will relocate its U.S. research and development activities to Cambridge in 2014. … The Massachusetts Life Sciences Center, which previously administered a research matching grant to Ipsen, announced the move.